| 前收市價 | 43.60 |
| 開市 | 42.70 |
| 買盤 | 33.30 |
| 賣出價 | 41.10 |
| 拍板 | 1,000.00 |
| 到期日 | 2025-01-17 |
| 今日波幅 | 41.60 - 43.60 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 160 |
ZacksRegeneron (REGN) Outperforms Industry YTD: What Lies Ahead?
Regeneron (REGN) maintains momentum on the back of Dupixent profits and efforts to develop oncology portfolio despite near-term challenges.
Investor's Business DailyWhy It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
There hasn't been a new COPD treatment in years. But Regeneron stock analysts are closely watching a pair of key FDA decisions.
Investor's Business DailyWhy Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club
Regeneron stock joined the 1,000-club this month as enthusiasm grows for its blockbuster drug, Dupixent, in COPD treatment.
